Skip to main content
. 2023 Jun 21;24:34. doi: 10.1186/s12863-023-01133-6

Table 2.

Laboratory indexes of the study participants

Parameters Casesa
(N = 285)
Controlsb
(N = 141)
Z Pc values
WBC (×109/L) 6.048 ± 1.898 6.683 ± 2.068 -3.056 0.002
NE (×109/L) 3.620 ± 1.429 4.602 ± 1.889 -2.021 0.043
LY (×109/L) 1.405 ± 0.683 1.851 ± 0.538 -3.121 0.002
MONO (×109/L) 0.339 ± 0.156 0.347 ± 0.126 -0.853 0.394
EOS (×109/L) 0.046 ± 0.060 0.065 ± 0.058 -1.264 0.206
BAS (×109/L) 0.017 ± 0.017 0.025 ± 0.014 -3.315 0.001
RBC (×1012/L) 4.398 ± 0.974 4.811 ± 0.606 -2.989 0.003
HB (g/L) 131.375 ± 29.748 144.500 ± 18.368 -3.261 0.001
PLT (×109/L) 214.875 ± 83.806 247.518 ± 53.034 -0.775 0.438
ALB (g/L) 44.461 ± 5.609 49.261 ± 3.149 -6.897 < 0.001
ALT (U/L) 35.311 ± 49.912 29.313 ± 27.707 -1.45 0.147
AST (U/L) 32.732 ± 31.802 21.171 ± 6.054 -1.153 0.249
Scr (µmol/L) 66.829 ± 12.887 68.875 ± 12.651 -0.121 0.904
BUN (mmol/L) 4.820 ± 1.208 4.798 ± 1.246 -1.283 0.199
TBIL (µmol/L) 10.343 ± 6.128 11.614 ± 5.188 -2.026 0.043
DBIL (µmol/L) 3.334 ± 1.665 4.316 ± 2.259 -4.163 < 0.001
IBIL (µmol/L) 7.009 ± 4.798 7.298 ± 3.102 -0.983 0.326
D-dimer (µg/L) 330.688 ± 299.289 256.964 ± 300.139 -0.906 0.365
PT (s) 11.405 ± 2.186 11.421 ± 0.643 -0.644 0.520
INR 2.941 ± 14.431 0.993 ± 0.058 -0.41 0.681
PTA (%) 113.520 ± 8.446 104.079 ± 9.143 -0.221 0.825
APTT (s) 27.423 ± 4.373 27.082 ± 2.309 -0.474 0.635
FIB (g/L) 3.102 ± 0.859 2.425 ± 0.578 -4.577 < 0.001
TT (s) 16.763 ± 1.282 18.416 ± 5.985 -4.948 < 0.001
ESR (mm/h) 25.643 ± 26.681 11.821 ± 8.550 -2.919 0.004
CRP (mg/L) 9.672 ± 18.336 2.147 ± 12.127 -3.654 < 0.001
SAA (mg/L) 45.182 ± 86.163 12.886 ± 58.340 -5.634 < 0.001

ALB Albumin, ALT Alanine transaminase, APTT Activated partial thromboplastin time, AST Aspartate Aminotransferase, BAS Basophil, BUN Blood urea nitrogen, CRP C-reactive protein, DBIL Direct bilirubin, EOS Eosinophil, ESR Erythrocyte sedimentation rate, FIB Fibrinogen, HB Hemoglobin, IBIL Indirect bilirubin, INR International normalized ratio, LY Lymphocyt, MONO Monocyte, NE Neutrophil, PLT Platelet, PT Prothrombin time, PTA Prothrombin activity, RBC Red blood cell, SAA Serum amyloid A, Scr Serum creatinine, TBIL Total bilirubin, TT Thrombin time, WBC White blood cell

aModerate, severe and critical patients were defined as cases. bAsymptomatic infection subjects were defined as controls. cP value < 0.05 indicates statistical significance and was calculated by the Mann–Whitney U test